Mastering Thrombocytopenia Management Guidelines for SCE Haematology Success

Introduction

Thrombocytopenia is a critical haematological finding that medical professionals frequently encounter in clinical practice. For candidates preparing for the SCE (Specialist Certificate Examination) in Haematology, understanding the diagnosis and management of thrombocytopenia is essential. This comprehensive guide covers the key guidelines, diagnostic approaches, and management strategies you need to know for exam success.

Understanding Thrombocytopenia

Thrombocytopenia is defined as a platelet count below 150 × 10⁹/L. However, the clinical significance depends heavily on the severity and underlying cause. For exam purposes, remember the following classification:

• Mild: Platelet count 100-150 × 10⁹/L

• Moderate: Platelet count 50-100 × 10⁹/L

• Severe: Platelet count < 50 × 10⁹/L

• Very Severe: Platelet count < 20 × 10⁹/L (high risk of spontaneous bleeding)

Key Causes to Remember for SCE

Decreased Platelet Production

1. Bone Marrow Failure

   • Aplastic anaemia

   • Myelodysplastic syndromes (MDS)

   • Bone marrow infiltration (leukaemia, lymphoma, metastases)

   • Chemotherapy-induced marrow suppression

2. Nutritional Deficiencies

   • Vitamin B12 deficiency

   • Folate deficiency

   • Severe iron deficiency (rare)

3. Inherited Thrombocytopenias

   • Bernard-Soulier syndrome

   • May-Hegglin anomaly

   • Wiskott-Aldrich syndrome

Increased Platelet Destruction

1. Immune-Mediated

   • Immune thrombocytopenic purpura (ITP)

   • Drug-induced thrombocytopenia (heparin, quinine, sulfa antibiotics)

   • Post-transfusion purpura

   • Antiphospholipid syndrome

   • Systemic lupus erythematosus (SLE)

2. Non-Immune

   • Disseminated intravascular coagulation (DIC)

   • Thrombotic microangiopathies (TTP, HUS, DIC)

   • Mechanical prosthetic heart valves

   • Hypersplenism

Dilutional Thrombocytopenia

• Massive blood transfusion

• Cardiopulmonary bypass

Diagnostic Approach

History and Examination

Key points to elicit in history:

• Bleeding manifestations: Petechiae, purpura, epistaxis, menorrhagia

• Recent infections: Viral infections commonly precede ITP

• Medication review: Especially heparin (HIT)

• Family history: Inherited thrombocytopenias

• Systemic symptoms: Weight loss, night sweats (malignancy)

Initial Investigations

1. Full Blood Count with Film Review

   • Confirm thrombocytopenia

   • Look for other cytopenias (pancytopenia suggests bone marrow problem)

   • Examine film for platelet morphology

   • Schistocytes (TTP/HUS), large platelets (Bernard-Soulier)

2. Coagulation Screen

   • PT, APTT, fibrinogen, D-dimers (for DIC workup)

3. Liver Function Tests

   • Hypersplenism in liver disease

   • Alcoholic liver disease

4. Renal Function

   • HUS/TTP associated with renal impairment

Special Investigations

• Bone Marrow Aspirate: Essential when production defect suspected

• Autoimmune Screen: ANA, anti-dsDNA for SLE

• Heparin-Induced Thrombocytopenia (HIT) Testing: If suspected

• HIV, Hepatitis B/C: Viral causes

• Platelet Antibodies: For ITP diagnosis

Heparin-Induced Thrombocytopenia (HIT) - High-Yield Topic

HIT is a crucial topic for SCE as it represents a potentially life-threatening drug reaction with thrombotic complications.

Key Features

• Timing: Usually occurs 5-10 days after heparin exposure (or earlier if recent exposure)

• Platelet Count Fall: >50% drop from baseline

• Thrombosis: Can be venous or arterial; limb vein DVT and PE most common

• Antibody-mediated: Anti-PF4/heparin antibodies

Management (4T Score Pre-test)

1. Stop all heparin immediately

2. Alternative anticoagulation: Direct thrombin inhibitors (argatroban, bivalirudin) or fondaparinux

3. Avoid platelet transfusions unless life-threatening bleeding

4. Document heparin allergy in patient's records

Immune Thrombocytopenic Purpura (ITP) - High-Yield Topic

ITP is an autoimmune disorder characterized by isolated thrombocytopenia.

Diagnostic Criteria

• Isolated thrombocytopenia (<100 × 10⁹/L)

• Normal Hb, WCC

• Normal smear (no schistocytes)

• Normal coagulation

• Exclusion of secondary causes

Management Guidelines

First-Line Treatment

1. Corticosteroids

   • Prednisolone 1 mg/kg/day for 2-4 weeks

   • High-dose dexamethasone in acute settings

   • Consider IV methylprednisolone for severe bleeding

2. IV Immunoglobulin (IVIG)

   • 1 g/kg for 1-2 days

   • Faster response than steroids

   • Used in:

     • Active bleeding

     • Need for rapid platelet increase

     • Contraindication to steroids

Second-Line Treatments

• Rituximab: Anti-CD20 monoclonal antibody

• Thrombopoietin Receptor Agonists:

  • Eltrombopag

  • Romiplostim

• Splenectomy: For refractory cases

• Azathioprine, cyclophosphamide: Immunosuppressants

Emergency Management (Severe Bleeding)

• IV methylprednisolone 1 g daily for 3 days

• IVIG 1 g/kg daily for 2 days

• Platelet transfusion (temporary)

• Consider tranexamic acid for mucosal bleeding

Thrombotic Microangiopathies

Thrombotic Thrombocytopenic Purpura (TTP)

• Pentad: Thrombocytopenia, microangiopathic haemolytic anaemia, neurological symptoms, renal dysfunction, fever

• ADAMTS13 deficiency (severely reduced <10%)

• Plasma exchange is mainstay of treatment

• Steroids, rituximab, caplacizumab as adjuncts

Key Differentiating Features

Management Based on Platelet Count

Platelet Count > 50 × 10⁹/L

• Usually no intervention needed

• Treat underlying cause

• Monitor platelet count

Platelet Count 20-50 × 10⁹/L

• Consider treatment if bleeding

• Avoid antiplatelet drugs

• Surgical procedures may require platelet transfusion

Platelet Count < 20 × 10⁹/L

• Treatment usually indicated

• Avoid contact sports

• Consider platelet transfusion for active bleeding or invasive procedures

Platelet Count < 10 × 10⁹/L with bleeding

• Emergency treatment required

• IVIG, steroids, platelet transfusion

• Investigate for underlying cause

Exam Tips and Common Pitfalls

Remember for SCE:

1. Always identify the underlying cause - thrombocytopenia is a sign, not a diagnosis

2. Film review is crucial - look for schistocytes, abnormal platelet morphology

3. HIT must be considered in any patient on heparin with new thrombocytopenia

4. ITP is a diagnosis of exclusion - rule out secondary causes

5. Treatment depends on bleeding risk, not just platelet count

6. TTP is a medical emergency - don't delay treatment for test results

Common SCE Questions:

• "A patient develops thrombocytopenia 7 days after starting unfractionated heparin - what is your management?"

• "A patient with thrombocytopenia and schistocytes on film - what is your differential?"

• "A pregnant woman with thrombocytopenia - how does your approach differ?"

Conclusion

Mastering thrombocytopenia management requires understanding both the underlying pathophysiology and current treatment guidelines. Focus on the key differentials, remember the red flags (HIT, TTP), and always treat the underlying cause. With systematic approach and thorough knowledge of these guidelines, you will be well-prepared for your SCE Haematology examination.

Good luck with your SCE Haematology preparation!